Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Ngm Biopharmaceuticals Inc

Ngm Biopharmaceuticals Inc (NGM)

Market is closed
News
Hedge Fund and Insider Trading News: Ray Dalio, David Tepper, Sanjay Shah, Deerfield Management, Coatue Management, Dicks Sporting Goods Inc (DKS), and More

Hedge Fund and Insider Trading News: Ray Dalio, David Tepper, Sanjay Shah, Deerfield Management, Coatue Management, Dicks Sporting Goods Inc (DKS), and More

Like most so-called Tiger Cubs, the tech-focused hedge fund Coatue has lost significant money this year.

Keep Reading →

June 3rd, 2022 - Hedge Funds Insider Trading

10 Best Biotech and AI Stocks To Buy According To Quant Billionaire Jim Simons

10 Best Biotech and AI Stocks To Buy According To Quant Billionaire Jim Simons

Euclidean Capital is the family office of billionaire hedge fund manager James "Jim" Simons.

Keep Reading →

January 28th, 2022 - Hedge Funds News

Hedge Funds Are Crazy About NGM Biopharmaceuticals, Inc. (NGM)

Hedge Funds Are Crazy About NGM Biopharmaceuticals, Inc. (NGM)

Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).

Keep Reading →

January 12th, 2022 - Hedge Funds News

Hedge Funds Are Piling Into NGM Biopharmaceuticals, Inc. (NGM)

Hedge Funds Are Piling Into NGM Biopharmaceuticals, Inc. (NGM)

Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually don't make them change their opinion towards a...

Keep Reading →

October 29th, 2021 - Hedge Funds News

5 Pharmaceutical Stocks to Buy According to Jim Simons’ Euclidean Capital

5 Pharmaceutical Stocks to Buy According to Jim Simons’ Euclidean Capital

Below is the list of 5 pharmaceutical stocks to buy according to Jim Simons’ Euclidean Capital.

Keep Reading →

October 27th, 2021 - Hedge Funds News

5 Best Pharma and Biotech Stocks to Buy According to Jim Simons' Euclidean Capital

5 Best Pharma and Biotech Stocks to Buy According to Jim Simons' Euclidean Capital

In this article, we discuss the 5 best pharma and biotech stocks to buy according to Jim Simons' Euclidean Capital.

Keep Reading →

July 28th, 2021 - Hedge Funds News

Were Hedge Funds Right About NGM Biopharmaceuticals, Inc. (NGM)?

Were Hedge Funds Right About NGM Biopharmaceuticals, Inc. (NGM)?

In this article we will analyze whether NGM Biopharmaceuticals, Inc.

Keep Reading →

July 26th, 2021 - Hedge Funds News

Is NGM A Good Stock To Buy Now?

Is NGM A Good Stock To Buy Now?

In this article we will check out the progression of hedge fund sentiment towards NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) and determine whether it is a good investment right now.

Keep Reading →

December 11th, 2020 - Hedge Funds News

Were Hedge Funds Right About Warming Up To NGM Biopharmaceuticals, Inc. (NGM)?

Were Hedge Funds Right About Warming Up To NGM Biopharmaceuticals, Inc. (NGM)?

How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.

Keep Reading →

July 5th, 2020 - Hedge Funds News

NGM Biopharmaceuticals, Inc. (NGM): Were Hedge Funds Right About This Stock?

NGM Biopharmaceuticals, Inc. (NGM): Were Hedge Funds Right About This Stock?

Will the new coronavirus cause a recession in US in the next 6 months? On February 27th, we put the probability at 75% and we predicted that the market will decline by at least 20% in (Recession is Imminent...

Keep Reading →

May 6th, 2020 - Hedge Funds News